Skip to main content

Find Clinical Trials

Home
Conditions
Urogenital Neoplasms

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

11,824 public trials 2,516 recruiting studies

Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

UroCCR Database: French Research Network for Kidney Cancer -UroCCR

NCT03293563

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Cancer, +9 more
Locations: Hopital Universitaire de Bruxelles Brussels, Belgium

CHU Angers Angers, France

CHU Bordeaux Bordeaux, France

Clinique TIVOLI-DUCOS Bordeaux, France

View all 68 locations

View Trial Details

Recruiting

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

NCT05568680

Conditions: Adenoma, Adnexal Diseases, Cholangiocarcinoma Recurrent, +26 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

University of Kansas Cancer Center Westwood, Kansas, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing

NCT07387263

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +39 more
Locations: Sunnybrook Hospital Toronto, Ontario, Canada

Mount Sinai Hospital Toronto, Ontario, Canada

View Trial Details

Recruiting

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

NCT06835972

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: Johns Hopkins University (Data Collection Only) Baltimore, Maryland, United States

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

View Trial Details

Recruiting

Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer

NCT07667192

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +33 more
Locations: Affidea NU-MED Center of Oncological Diagnostics and Therapy Zamość, Lublin Voivodeship, Poland

View Trial Details

Recruiting

Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance

NCT06995833

Conditions: Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations: Research Site Seoul, South Korea

View Trial Details

Recruiting

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

NCT04641247

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +16 more
Locations: GSK Investigational Site Tucson, Arizona, United States

GSK Investigational Site Encinitas, California, United States

GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site Whittier, California, United States

View all 25 locations

View Trial Details

Recruiting

NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife)

NCT06890273

Conditions: Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations: Research Site Amberg, Germany

Research Site Bad Nauheim, Germany

Research Site Bautzen, Germany

Research Site Berlin, Germany

View all 49 locations

View Trial Details

Recruiting

Engineered Immune Effectors Against Ovarian Cancer

NCT03362606

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China

View Trial Details

Recruiting

A Study of LY4175408 in Participants With Advanced Cancer

NCT07046923

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +28 more
Locations: Stanford Medicine Cancer Center Stanford, California, United States

Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute Orlando, Florida, United States

Florida Cancer Specialists - Sarasota Sarasota, Florida, United States

The University of Chicago Medical Center (UCMC) Chicago, Illinois, United States

View all 27 locations

View Trial Details